Many studies have demonstrated that RPLP2 is highly expressed and associated with poor prognosis in various cancer types such as, breast, colon and lung cancers, and it may involve in carcinogens by affecting the translation of specific cellular mRNAs [17–20]. This evidence concerns the gene RPLP2 and cancer.